Targeting cancer-associated fibroblasts for treatment of ER+ breast cancer: A mathematical modeling perspective and optimization of treatment strategies
This study employs a mathematical modeling framework and optimal control theory to demonstrate that targeting cancer-associated fibroblasts through specific signaling inhibition strategies can significantly enhance the efficacy of endocrine therapies for ER+ breast cancer by mitigating estrogen-independent tumor growth.